Concepts (187)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Heat-Shock Proteins | 17 | 2023 | 178 | 4.690 |
Why?
|
| Molecular Chaperones | 12 | 2023 | 173 | 2.500 |
Why?
|
| Saccharomyces cerevisiae Proteins | 7 | 2017 | 266 | 2.140 |
Why?
|
| Saccharomyces cerevisiae | 7 | 2023 | 405 | 1.670 |
Why?
|
| HSP70 Heat-Shock Proteins | 8 | 2023 | 72 | 1.500 |
Why?
|
| Adenosine Triphosphate | 8 | 2022 | 265 | 1.420 |
Why?
|
| Models, Molecular | 22 | 2021 | 1062 | 1.230 |
Why?
|
| Thermus thermophilus | 5 | 2012 | 11 | 0.910 |
Why?
|
| Leishmania | 2 | 2023 | 33 | 0.910 |
Why?
|
| Protein Folding | 7 | 2016 | 216 | 0.840 |
Why?
|
| Escherichia coli Proteins | 5 | 2022 | 310 | 0.830 |
Why?
|
| Bacterial Proteins | 5 | 2012 | 943 | 0.830 |
Why?
|
| HSP90 Heat-Shock Proteins | 4 | 2020 | 39 | 0.810 |
Why?
|
| Mitochondria | 5 | 2023 | 766 | 0.810 |
Why?
|
| Protein Multimerization | 7 | 2021 | 150 | 0.770 |
Why?
|
| Protein Conformation | 13 | 2019 | 734 | 0.770 |
Why?
|
| Cryoelectron Microscopy | 5 | 2019 | 239 | 0.760 |
Why?
|
| Metabolism, Inborn Errors | 1 | 2023 | 125 | 0.710 |
Why?
|
| Shewanella | 1 | 2019 | 10 | 0.610 |
Why?
|
| HSP40 Heat-Shock Proteins | 3 | 2018 | 22 | 0.610 |
Why?
|
| Binding Sites | 9 | 2022 | 1148 | 0.610 |
Why?
|
| Adenosine Triphosphatases | 7 | 2012 | 189 | 0.610 |
Why?
|
| GTP-Binding Proteins | 1 | 2019 | 161 | 0.570 |
Why?
|
| Crystallography, X-Ray | 9 | 2017 | 365 | 0.570 |
Why?
|
| Protein Aggregates | 2 | 2018 | 43 | 0.560 |
Why?
|
| Protein Unfolding | 1 | 2017 | 14 | 0.550 |
Why?
|
| Protein Structure, Tertiary | 9 | 2012 | 719 | 0.510 |
Why?
|
| Protein Binding | 7 | 2021 | 1674 | 0.450 |
Why?
|
| Mitochondrial Proteins | 2 | 2020 | 277 | 0.430 |
Why?
|
| Amino Acid Sequence | 10 | 2019 | 2422 | 0.430 |
Why?
|
| Mitochondrial Membranes | 2 | 2010 | 32 | 0.410 |
Why?
|
| Metalloendopeptidases | 2 | 2010 | 103 | 0.400 |
Why?
|
| Amino Acid Motifs | 5 | 2016 | 194 | 0.340 |
Why?
|
| Chaperonin 60 | 1 | 2010 | 32 | 0.330 |
Why?
|
| Peptides | 3 | 2022 | 725 | 0.320 |
Why?
|
| Molecular Sequence Data | 10 | 2016 | 3534 | 0.310 |
Why?
|
| Substrate Specificity | 4 | 2022 | 286 | 0.300 |
Why?
|
| Proteolysis | 2 | 2021 | 195 | 0.300 |
Why?
|
| RNA Polymerase II | 2 | 2000 | 90 | 0.290 |
Why?
|
| Endopeptidase Clp | 4 | 2021 | 7 | 0.270 |
Why?
|
| Protein Structure, Quaternary | 4 | 2012 | 93 | 0.250 |
Why?
|
| Protein Domains | 3 | 2023 | 248 | 0.250 |
Why?
|
| Mycobacterium tuberculosis | 1 | 2010 | 425 | 0.250 |
Why?
|
| Escherichia coli | 6 | 2021 | 983 | 0.240 |
Why?
|
| Promoter Regions, Genetic | 2 | 2000 | 1220 | 0.230 |
Why?
|
| Sequence Homology, Amino Acid | 5 | 2016 | 622 | 0.210 |
Why?
|
| Amino Acyl-tRNA Synthetases | 1 | 2023 | 26 | 0.200 |
Why?
|
| Intrinsically Disordered Proteins | 1 | 2024 | 63 | 0.200 |
Why?
|
| Leishmania mexicana | 1 | 2023 | 6 | 0.200 |
Why?
|
| Cloning, Molecular | 2 | 2019 | 787 | 0.200 |
Why?
|
| Protein Structure, Secondary | 7 | 2012 | 238 | 0.200 |
Why?
|
| Ubiquitin-Protein Ligases | 1 | 2006 | 364 | 0.200 |
Why?
|
| Receptors, Androgen | 1 | 2006 | 419 | 0.190 |
Why?
|
| Leishmaniasis | 1 | 2023 | 40 | 0.190 |
Why?
|
| Hydrolysis | 2 | 2019 | 140 | 0.170 |
Why?
|
| Stress, Physiological | 1 | 2023 | 265 | 0.160 |
Why?
|
| Proteins | 1 | 2005 | 1014 | 0.160 |
Why?
|
| Mutation | 4 | 2023 | 6197 | 0.150 |
Why?
|
| Protein Conformation, alpha-Helical | 1 | 2019 | 16 | 0.150 |
Why?
|
| Oxidative Phosphorylation | 1 | 2020 | 130 | 0.150 |
Why?
|
| Transcription Factors | 2 | 2000 | 2445 | 0.150 |
Why?
|
| DNA Topoisomerases, Type II | 2 | 1997 | 26 | 0.140 |
Why?
|
| Allosteric Regulation | 2 | 2016 | 61 | 0.140 |
Why?
|
| Transcription Factors, TFII | 1 | 1998 | 8 | 0.140 |
Why?
|
| Archaea | 1 | 1998 | 11 | 0.140 |
Why?
|
| Protein Transport | 2 | 2017 | 363 | 0.140 |
Why?
|
| Humans | 20 | 2023 | 132041 | 0.140 |
Why?
|
| Protein Aggregation, Pathological | 1 | 2018 | 38 | 0.140 |
Why?
|
| Signal Transduction | 3 | 2019 | 4696 | 0.130 |
Why?
|
| Novobiocin | 1 | 1997 | 2 | 0.130 |
Why?
|
| Coumarins | 1 | 1997 | 23 | 0.130 |
Why?
|
| 5'-Nucleotidase | 1 | 2016 | 21 | 0.120 |
Why?
|
| Allosteric Site | 1 | 2016 | 12 | 0.120 |
Why?
|
| Crystallization | 2 | 2007 | 83 | 0.120 |
Why?
|
| Amino Acid Substitution | 2 | 2016 | 410 | 0.120 |
Why?
|
| Homeostasis | 1 | 2020 | 715 | 0.120 |
Why?
|
| DNA Mutational Analysis | 1 | 2017 | 804 | 0.110 |
Why?
|
| tau Proteins | 1 | 2018 | 250 | 0.110 |
Why?
|
| Rabbits | 1 | 2016 | 579 | 0.110 |
Why?
|
| Pharmacogenetics | 1 | 2016 | 202 | 0.110 |
Why?
|
| Bacteria | 1 | 2019 | 537 | 0.110 |
Why?
|
| Germ-Line Mutation | 1 | 2016 | 375 | 0.100 |
Why?
|
| Peptide Mapping | 1 | 2013 | 33 | 0.100 |
Why?
|
| Recombinant Fusion Proteins | 1 | 2016 | 695 | 0.100 |
Why?
|
| Conserved Sequence | 2 | 2010 | 282 | 0.100 |
Why?
|
| Computer Simulation | 1 | 2016 | 681 | 0.100 |
Why?
|
| Transcription, Genetic | 1 | 1998 | 1398 | 0.100 |
Why?
|
| Recombinant Proteins | 2 | 2007 | 1320 | 0.090 |
Why?
|
| DNA-Binding Proteins | 1 | 2000 | 1964 | 0.090 |
Why?
|
| Mutagenesis, Site-Directed | 3 | 2012 | 300 | 0.090 |
Why?
|
| Molecular Weight | 2 | 2003 | 283 | 0.080 |
Why?
|
| Enzyme Stability | 1 | 2010 | 58 | 0.080 |
Why?
|
| beta-Galactosidase | 1 | 2010 | 135 | 0.080 |
Why?
|
| Hot Temperature | 1 | 2010 | 144 | 0.080 |
Why?
|
| Yeasts | 1 | 2009 | 42 | 0.080 |
Why?
|
| Species Specificity | 1 | 2010 | 496 | 0.080 |
Why?
|
| Fungal Proteins | 1 | 2009 | 132 | 0.070 |
Why?
|
| Receptors, Glucocorticoid | 2 | 2006 | 105 | 0.070 |
Why?
|
| Viral Proteins | 2 | 2021 | 339 | 0.070 |
Why?
|
| Magnetic Resonance Spectroscopy | 2 | 2021 | 284 | 0.070 |
Why?
|
| Infant | 1 | 2023 | 13343 | 0.070 |
Why?
|
| Neurodegenerative Diseases | 1 | 2010 | 290 | 0.070 |
Why?
|
| Models, Biological | 2 | 2021 | 1394 | 0.060 |
Why?
|
| Adenine Nucleotides | 1 | 2007 | 37 | 0.060 |
Why?
|
| Animals | 5 | 2023 | 34262 | 0.060 |
Why?
|
| Hormone Antagonists | 1 | 2006 | 45 | 0.060 |
Why?
|
| Base Sequence | 3 | 2000 | 2783 | 0.060 |
Why?
|
| Receptors, Steroid | 2 | 2005 | 172 | 0.060 |
Why?
|
| Mifepristone | 1 | 2006 | 89 | 0.060 |
Why?
|
| Antineoplastic Agents | 1 | 2016 | 1811 | 0.060 |
Why?
|
| Receptors, Progesterone | 2 | 2006 | 681 | 0.060 |
Why?
|
| Enzyme Activation | 1 | 2007 | 589 | 0.060 |
Why?
|
| Receptors, Mineralocorticoid | 2 | 2006 | 17 | 0.060 |
Why?
|
| Proteasome Endopeptidase Complex | 1 | 2006 | 244 | 0.060 |
Why?
|
| Heat-Shock Response | 1 | 2004 | 34 | 0.050 |
Why?
|
| Cyclophilin A | 1 | 2024 | 14 | 0.050 |
Why?
|
| Threonine-tRNA Ligase | 1 | 2023 | 1 | 0.050 |
Why?
|
| Aminoacylation | 1 | 2023 | 4 | 0.050 |
Why?
|
| Image Processing, Computer-Assisted | 1 | 2007 | 612 | 0.050 |
Why?
|
| Protein Denaturation | 1 | 2003 | 48 | 0.050 |
Why?
|
| Peptide Fragments | 1 | 2007 | 693 | 0.050 |
Why?
|
| RNA, Transfer | 1 | 2023 | 69 | 0.050 |
Why?
|
| Structure-Activity Relationship | 2 | 2009 | 555 | 0.050 |
Why?
|
| Phosphorylation | 1 | 2006 | 1571 | 0.050 |
Why?
|
| Neoplasms | 1 | 2016 | 2968 | 0.040 |
Why?
|
| Peptidylprolyl Isomerase | 1 | 2021 | 35 | 0.040 |
Why?
|
| Flow Cytometry | 1 | 2023 | 771 | 0.040 |
Why?
|
| Protein Interaction Mapping | 1 | 2021 | 90 | 0.040 |
Why?
|
| Aldosterone | 1 | 2000 | 58 | 0.040 |
Why?
|
| Ribosomes | 1 | 2021 | 124 | 0.040 |
Why?
|
| Transcription Factor TFIIB | 1 | 2000 | 5 | 0.040 |
Why?
|
| RNA-Binding Proteins | 1 | 2024 | 552 | 0.040 |
Why?
|
| TATA-Box Binding Protein | 1 | 2000 | 31 | 0.040 |
Why?
|
| Mutagenesis | 1 | 2021 | 335 | 0.040 |
Why?
|
| Hematopoietic Stem Cells | 1 | 2024 | 550 | 0.040 |
Why?
|
| Genome, Bacterial | 1 | 2021 | 208 | 0.040 |
Why?
|
| Pregnancy Complications, Cardiovascular | 1 | 2000 | 110 | 0.040 |
Why?
|
| Cell Survival | 2 | 2016 | 849 | 0.040 |
Why?
|
| Phylogeny | 1 | 2021 | 716 | 0.040 |
Why?
|
| Gene Expression Regulation, Archaeal | 1 | 1998 | 1 | 0.030 |
Why?
|
| DNA, Archaeal | 1 | 1998 | 4 | 0.030 |
Why?
|
| TATA Box | 1 | 1998 | 15 | 0.030 |
Why?
|
| Progesterone | 1 | 2000 | 446 | 0.030 |
Why?
|
| Transcription Factor TFIID | 1 | 1998 | 17 | 0.030 |
Why?
|
| Gene Deletion | 1 | 2021 | 773 | 0.030 |
Why?
|
| Solutions | 1 | 1997 | 50 | 0.030 |
Why?
|
| DNA Gyrase | 1 | 1997 | 26 | 0.030 |
Why?
|
| Nucleic Acid Conformation | 1 | 1998 | 180 | 0.030 |
Why?
|
| Thermodynamics | 1 | 1997 | 148 | 0.030 |
Why?
|
| Topoisomerase II Inhibitors | 1 | 1996 | 12 | 0.030 |
Why?
|
| Molecular Motor Proteins | 2 | 2007 | 28 | 0.030 |
Why?
|
| COS Cells | 2 | 2006 | 249 | 0.030 |
Why?
|
| Cell Differentiation | 1 | 2023 | 1950 | 0.030 |
Why?
|
| Cell Line | 1 | 2020 | 2591 | 0.030 |
Why?
|
| Models, Genetic | 1 | 1998 | 752 | 0.030 |
Why?
|
| Point Mutation | 2 | 2009 | 339 | 0.030 |
Why?
|
| DNA | 1 | 2000 | 1440 | 0.030 |
Why?
|
| Anti-Infective Agents | 1 | 1996 | 265 | 0.030 |
Why?
|
| HEK293 Cells | 1 | 2016 | 810 | 0.030 |
Why?
|
| Chromatography, Gel | 1 | 2012 | 63 | 0.020 |
Why?
|
| Hypertension | 1 | 2000 | 1364 | 0.020 |
Why?
|
| ATP-Dependent Proteases | 1 | 2009 | 13 | 0.020 |
Why?
|
| ATPases Associated with Diverse Cellular Activities | 1 | 2009 | 84 | 0.020 |
Why?
|
| Protein Subunits | 1 | 2009 | 161 | 0.020 |
Why?
|
| Catalytic Domain | 1 | 2009 | 161 | 0.020 |
Why?
|
| Kinetics | 1 | 2009 | 1093 | 0.020 |
Why?
|
| Brain | 1 | 2018 | 3251 | 0.010 |
Why?
|
| Genes, Reporter | 1 | 2006 | 350 | 0.010 |
Why?
|
| Protein Engineering | 1 | 2004 | 62 | 0.010 |
Why?
|
| Sequence Homology, Nucleic Acid | 1 | 2004 | 254 | 0.010 |
Why?
|
| Energy Metabolism | 1 | 2009 | 786 | 0.010 |
Why?
|
| Anti-Bacterial Agents | 1 | 1996 | 2578 | 0.010 |
Why?
|
| Multiprotein Complexes | 1 | 2004 | 194 | 0.010 |
Why?
|
| Transcriptional Activation | 1 | 2005 | 417 | 0.010 |
Why?
|
| Glucocorticoids | 1 | 2005 | 352 | 0.010 |
Why?
|
| Receptors, Cytoplasmic and Nuclear | 1 | 2005 | 329 | 0.010 |
Why?
|
| Binding, Competitive | 1 | 2000 | 147 | 0.010 |
Why?
|
| Dimerization | 1 | 2000 | 139 | 0.010 |
Why?
|
| Steroids | 1 | 2000 | 172 | 0.010 |
Why?
|
| Female | 2 | 2023 | 71380 | 0.010 |
Why?
|
| Heterozygote | 1 | 2000 | 728 | 0.010 |
Why?
|
| 4-Quinolones | 1 | 1996 | 1 | 0.010 |
Why?
|
| Pedigree | 1 | 2000 | 1719 | 0.010 |
Why?
|
| Enzyme Inhibitors | 1 | 1996 | 567 | 0.010 |
Why?
|
| Pregnancy | 1 | 2000 | 7588 | 0.000 |
Why?
|
| Adolescent | 1 | 2000 | 21018 | 0.000 |
Why?
|
| Male | 1 | 2000 | 65425 | 0.000 |
Why?
|